Pei‐Ju Chao
Papers
3
Total Citations
12
H-Index
3
About
Pei-Ju Chao is a medical physicist and radiation oncology researcher whose work centers on treatment planning optimization and radiation safety in advanced radiosurgery systems, with a particular focus on the CyberKnife M6 robotic radiosurgery platform. Chao's most significant contributions lie in the critical assessment of secondary cancer risk (SCR) associated with stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS), addressing a clinically vital yet often underexplored dimension of cancer treatment. By evaluating both lung cancer patients treated with CyberKnife's lung-optimized treatment module and patients with benign intracranial lesions, Chao has helped illuminate how collimator choice — comparing multileaf collimator-based and IRIS variable aperture collimator plans — influences both plan quality and long-term radiation-induced cancer risk. These findings carry meaningful implications for clinical decision-making, especially for patients with benign conditions who face decades of post-treatment life. Chao's 2024 mini review synthesizes this evolving body of evidence, positioning their work as a foundational reference in radiosurgery safety literature. With accumulated citations across multiple studies, Chao's research provides radiation oncologists and medical physicists with data-driven guidance for balancing therapeutic efficacy against the risk of treatment-induced secondary malignancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3